Stay updated on Merck & Co. Press Releases

Sign up to get notified when there's something new on the Merck & Co. Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Merck & Co. Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    New items dated January 07, 2026 have been added to the News releases list, including the Phase 3 trial for Calderasib and the acquisition of Cidara Therapeutics. Older items like the 8th Annual Evercore ISI conference and the November 2025 updates have been removed.
    Difference
    6%
    Check dated 2026-01-08T06:35:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer copyright year updated from 2025 to 2026 on the News releases page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-01T03:19:10.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added December 19, 2025: Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans; Removed November 19, 2025: Merck Announces Positive Topline Results from the Phase 3 trial of Doravirine/Islatravir in treatment-naïve HIV-1 infection.
    Difference
    5%
    Check dated 2025-12-24T23:36:10.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added two new press releases dated December 17, 2025 and December 12, 2025, and removed two older releases: European Commission Approves Subcutaneous Administration of KEYTRUDA® for All Adult Indications Approved in the EU and Merck Announces First-Quarter 2026 Dividend.
    Difference
    6%
    Check dated 2025-12-17T19:56:53.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added the December 04, 2025 press release announcing FDA Conditionally Approves Merck Animal Health’s EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm. Deleted the November 18, 2025 release detailing WINREVAIR’s CADENCE study results.
    Difference
    5%
    Check dated 2025-12-10T19:13:48.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added a December 01, 2025 news release about Alzheimer’s disease candidates MK-2214 and MK-1167 at CTAD 2025. Removed the November 17, 2025 release commemorating Merck’s 5 billion Mectizan treatments donated.
    Difference
    5%
    Check dated 2025-12-03T14:42:51.000Z thumbnail image

Stay in the know with updates to Merck & Co. Press Releases

Enter your email address, and we'll notify you when there's something new on the Merck & Co. Press Releases page.